NURIX THERAPEUTICS, INC. (NRIX)

SEC filing

NURIX THERAPEUTICS, INC.

NRIX · CIK 1549595

4 · Sep 2, 2026 · Chief Legal Officer Ring Christine sold 5,787 shares at $25.76/share ($149.1K); exercised options for 11.57K shares

Chief Legal Officer Ring Christine sold 5,787 shares at $25.76/share ($149.1K); exercised options for 11.57K shares

FORM 4

xslF345X06/wk-form4_1788392559.xmlSEC.gov

Graphics and non-inline formats (not embedded below).